Advertisement

Advertisement

Featured European Articles  


Trifluridine/Tipiracil (TAS‐102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program

Chiara Cremolini, Daniele Rossini, Erika Martinelli, Filippo Pietrantonio, Sara Lonardi, Silvia Noventa, Emiliano Tamburini, Giovanni Luca Frassineti, Stefania Mosconi, Federico Nichetti, Sabina Murgioni, Teresa Troiani, Beatrice Borelli, Gemma Zucchelli, Alessandro Dal Maso, Vincenzo Sforza, Gianluca Masi, Carlotta Antoniotti, Maria Di Bartolomeo, Rosalba Miceli, Fortunato Ciardiello, Alfredo Falcone

The Oncologist first published on May 8, 2018; doi:10.1634/theoncologist.2017-0573


Genomic Profiling of HER2‐Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2‐Positive Advanced Gastric Cancer Treated with Trastuzumab

Asunción Díaz‐Serrano, Barbara Angulo, Carolina Dominguez, Roberto Pazo‐Cid, Antonieta Salud, Paula Jiménez‐Fonseca, Ana Leon, Maria Carmen Galan, Maria Alsina, Fernando Rivera, J. Carlos Plaza, Luis Paz‐Ares, Fernando Lopez‐Rios, Carlos Gómez‐Martín

The Oncologist first published on April 26, 2018; doi:10.1634/theoncologist.2017-0379


Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study)

Vittorio Stefoni, Cinzia Pellegrini, Alessandro Broccoli, Luca Baldini, Monica Tani, Emanuele Cencini, Amalia Figuera, Michela Ansuinelli, Elisa Bernocco, Maria Cantonetti, Maria Christina Cox, Filippo Ballerini, Chiara Rusconi, Carlo Visco, Luca Arcaini, Angelo Fama, Roberto Marasca, Stefano Volpetti, Alessia Castellino, Catello Califano, Marina Cavaliere, Guido Gini, Anna Marina Liberati, Gerardo Musuraca, Anna Lucania, Giuseppina Ricciuti, Lisa Argnani, Pier Luigi Zinzani

The Oncologist first published on April 19, 2018; doi:10.1634/theoncologist.2017-0597


Phase II Study of Preoperative Treatment with External Radiotherapy Plus Panitumumab in Low‐Risk, Locally Advanced Rectal Cancer (RaP Study/STAR‐03)

Carmine Pinto, Maurizio Di Bisceglie, Francesca Di Fabio, Annamaria Bochicchio, Tiziana Latiano, Stefano Cordio, Gerardo Rosati, Carlo Aschele, Antonella Marino, Francesca Bergamo, Sara Bustreo, Luca Frassineti, Fortunato Ciardiello, Angela Damato, Stefania Giaquinta, Daniela Baldari, Luca Boni

The Oncologist first published on March 9, 2018; doi:10.1634/theoncologist.2017-0484


Treatment and Survival of Patients with Colon Cancer Aged 80 Years and Older: A EURECCA International Comparison

Nina C.A. Vermeer, Yvette H.M. Claassen, Marloes G.M. Derks, Lene H. Iversen, Elizabeth van Eycken, Marianne G. Guren, Pawel Mroczkowski, Anna Martling, Robert Johansson, Tamara Vandendael, Arne Wibe, Bjorn Moller, Hans Lippert, Johanneke E.A. Portielje, Gerrit Jan Liefers, Koen C.M.J. Peeters, Cornelis J.H. van de Velde, Esther Bastiaannet

The Oncologist first published on March 22, 2018; doi:10.1634/theoncologist.2017-0551


Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG)

Germán Reyes‐Botero, Stéphanie Cartalat‐Carel, Olivier L. Chinot, Maryline Barrie, Luc Taillandier, Patrick Beauchesne, Isabelle Catry‐Thomas, Jérôme Barrière, Jean‐Sebastien Guillamo, Michel Fabbro, Didier Frappaz, Alexandra Benouaich‐Amiel, Emilie Le Rhun, Chantal Campello, Isabelle Tennevet, François Ghiringhelli, Marie‐Laure Tanguy, Karima Mokhtari, Jérôme Honnorat, Jean‐Yves Delattre

The Oncologist first published on February 22, 2018; doi:10.1634/theoncologist.2017-0689


Early Gastric Cancer: Clinical Behavior and Treatment Options. Results of an Italian Multicenter Study on Behalf of the Italian Gastric Cancer Research Group (GIRCG)

Luca Saragoni, Emanuela Scarpi, Alessandra Ravaioli, Paolo Morgagni, Franco Roviello, Carla Vindigni, Stefano Rausei, Anna Maria Chiaravalli, Uberto Fumagalli, Paola Spaggiari, Fausto Rosa, Riccardo Ricci, Annibale Donini, Paolo Giovenali, Anna Tomezzoli, Giovanni De Manzoni

The Oncologist first published on January 31, 2018; doi:10.1634/theoncologist.2017-0488


EMA Review of Daratumumab for the Treatment of Adult Patients with Multiple Myeloma

Kyriaki Tzogani, Elisabeth Penninga, Marie Louise Schougaard Christiansen, Doris Hovgaard, Sinan B. Sarac, Jorge Camarero Jimenez, Isabel Garcia, Marta Lafuente, Arantxa Sancho‐López, Tomas Salmonson, Christian Gisselbrecht, Francesco Pignatti

The Oncologist first published on January 25, 2018; doi:10.1634/theoncologist.2017-0328


Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real‐World Data from the Spanish Tumor Registry (R‐GETNE)

Barbara Nuñez‐Valdovinos, Alberto Carmona‐Bayonas, Paula Jimenez‐Fonseca, Jaume Capdevila, Ángel Castaño‐Pascual, Marta Benavent, Jose Javier Pi Barrio, Alex Teule, Vicente Alonso, Ana Custodio, Monica Marazuela, Ángel Segura, Adolfo Beguiristain, Marta Llanos, Maria Purificacion Martinez del Prado, Jose Angel Diaz‐Perez, Daniel Castellano, Isabel Sevilla, Carlos Lopez, Teresa Alonso, Rocio Garcia‐Carbonero

The Oncologist 2018; 23:422-432; first published on January 12, 2018; doi:10.1634/theoncologist.2017-0364


Clinical Usefulness of 18F‐Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero‐Pancreatic Neuroendocrine Neoplasms

Maria Rinzivillo, Stefano Partelli, Daniela Prosperi, Gabriele Capurso, Patrizia Pizzichini, Elsa Iannicelli, Elettra Merola, Francesca Muffatti, Francesco Scopinaro, Orazio Schillaci, Matteo Salgarello, Massimo Falconi, Gianfranco Delle Fave, Francesco Panzuto

The Oncologist 2018; 23:186-192; first published on November 8, 2017; doi:10.1634/theoncologist.2017-0278


Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma​

Silvia Stacchiotti, Olivier Mir, Axel Le Cesne, Bruno Vincenzi, Alexander Fedenko, Robert G. Maki, Neeta Somaiah, Shreyaskumar Patel, Mehedi Brahmi, Jean Y. Blay, Kjetil Boye, Kirsten Sundby Hall, Hans Gelderblom, Nadia Hindi, Javier Martin‐Broto, Hanna Kosela, Piotr Rutkowski, Antoine Italiano, Florence Duffaud, Eisuke Kobayashi, Paolo G. Casali, Salvatore Provenzano, Akira Kawai

The Oncologist 2018; 23:62-70; first published on July 28, 2017; doi:10.1634/theoncologist.2017-0161


Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy

Valentina Fanotto, Mario Uccello, Irene Pecora, Lorenza Rimassa, Francesco Leone, Gerardo Rosati, Daniele Santini, Riccardo Giampieri, Samantha Di Donato, Gianluca Tomasello, Nicola Silvestris, Filippo Pietrantonio, Francesca Battaglin, Antonio Avallone, Mario Scartozzi, Eufemia Stefania Lutrino, Davide Melisi, Lorenzo Antonuzzo, Antonio Pellegrino, Laura Ferrari, Roberto Bordonaro, Caterina Vivaldi, Lorenzo Gerratana, Silvia Bozzarelli, Roberto Filippi, Domenico Bilancia, Marco Russano, Giuseppe Aprile

The Oncologist 2017; 22:1463-1469; first published on August 31, 2017; doi:10.1634/theoncologist.2017-0158


Salvage Therapy in Advanced Adult Soft Tissue Sarcoma: A Systematic Review and Meta‐Analysis of Randomized Trials

Alessandro Comandone, Fausto Petrelli, Antonella Boglione, Sandro Barni

The Oncologist 2017; 22:1518-1527; first published on August 23, 2017; doi:10.1634/theoncologist.2016-0474


Neoadjuvant Therapy with Weekly Nanoparticle Albumin‐Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011‐02), a Multicenter, Non‐Randomized, Phase II Trial, with a Companion Biomarker Analysis

Miguel Martín, José I. Chacón, Antonio Antón, Arrate Plazaola, Elena García‐Martínez, Miguel A. Seguí, Pedro Sánchez‐Rovira, José Palacios, Lourdes Calvo, Carmen Esteban, Enrique Espinosa, Agusti Barnadas, Norberto Batista, Angel Guerrero, Montserrat Muñoz, Estefania Romio, César Rodríguez‐Martín, Rosalía Caballero, María I. Casas, Federico Rojo, Eva Carrasco, Silvia Antolín

The Oncologist 2017; 22:1301-1308; first published on July 12, 2017; doi:10.1634/theoncologist.2017-0052


The European Medicines Agency Review of Carfilzomib for the Treatment of Adult Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy

Kyriaki Tzogani, Jorge Camarero Jiménez, Isabel Garcia, Arantxa Sancho‐López, Marc Martin, Alexandre Moreau, Pierre Demolis, Tomas Salmonson, Jonas Bergh, Edward Laane, Heinz Ludwig, Christian Gisselbrecht, Francesco Pignatti

The Oncologist 2017; 22:1339-1346; first published on September 21, 2017; doi:10.1634/theoncologist.2017-0184


Prolonged Pemetrexed Infusion Plus Gemcitabine in Refractory Metastatic Colorectal Cancer: Preclinical Rationale and Phase II Study Results

Alessandro Passardi, Francesca Fanini, Livia Turci, Flavia Foca, Paola Rosetti, Silvia Ruscelli, Andrea Casadei Gardini, Martina Valgiusti, Claudio Dazzi, Maurizio Marangolo

The Oncologist 2017; 22:886-e79; first published on June 7, 2017; doi:10.1634/theoncologist.2017-0206


Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer

Marco Siano, Francesca Molinari, Vittoria Martin, Nicolas Mach, Martin Früh, Stefania Freguia, Irene Corradino, Michele Ghielmini, Milo Frattini, Vittoria Espeli

The Oncologist 2017; 22:782-e70; first published on June 7, 2017; doi:10.1634/theoncologist.2017-0069


A Phase II Study of Everolimus Plus Oral Prednisone in Patients with Metastatic Renal Cell Cancer

Cristian Lolli, Valentina Gallà, Giuseppe Schepisi, Domenico Barone, Salvatore Luca Burgio, Antonio Maugeri, Bernadette Vertogen, Dino Amadori, Ugo De Giorgi

The Oncologist 2017; 22:784-e74; first published on May 25, 2017; doi:10.1634/theoncologist.2017-0154


Accessibility, Availability, and Potential Benefits of Psycho‐Oncology Services: The Perspective of Community‐Based Physicians Providing Cancer Survivorship Care

Verena Zimmermann‐Schlegel, Mechthild Hartmann, Halina Sklenarova, Wolfgang Herzog, Markus W. Haun

The Oncologist 2017; 22:719-727; first published on April 24, 2017; doi:10.1634/theoncologist.2016-0245


Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical Evaluation

Aristotle Bamias, Bernard Escudier, Cora N. Sternberg, Flora Zagouri, Athanasios Dellis, Bob Djavan, Kimon Tzannis, Loukas Kontovinis, Konstantinos Stravodimos, Athanasios Papatsoris, Dionysios Mitropoulos, Charalampos Deliveliotis, Meletios‐Athanasios Dimopoulos, Constantine A. Constantinides

The Oncologist 2017; 22:667-679; first published on June 7, 2017; doi:10.1634/theoncologist.2016-0435


Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed Glioblastoma

Marco Skardelly, Elena Dangel, Julia Gohde, Susan Noell, Felix Behling, Guilherme Lepski, Christian Borchers, Marilin Koch, Jens Schittenhelm, Sotirios Bisdas, Aline Naumann, Frank Paulsen, Daniel Zips, Ulrike von Hehn, Rainer Ritz, Marcos Soares Tatagiba, Ghazaleh Tabatabai

The Oncologist 2017; 22:570-575; first published on March 30, 2017; doi:10.1634/theoncologist.2016-0347


Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study

Chiara Alessandra Cella, Giovanni Di Minno, Chiara Carlomagno, Michele Arcopinto, Anna Maria Cerbone, Elide Matano, Antonella Tufano, Florian Lordick, Biagio De Simone, Katja Sibylle Muehlberg, Dario Bruzzese, Laura Attademo, Claudia Arturo, Marta Sodano, Roberto Moretto, Ersilia La Fata, Sabino De Placido

The Oncologist 2017; 22:601-608; first published on April 19, 2017; doi:10.1634/theoncologist.2016-0246


Platinum‐Fluoropyrimidine and Paclitaxel‐Based Chemotherapy in the Treatment of Advanced Anal Cancer Patients

Francesco Sclafani, Federica Morano, David Cunningham, Chiara Baratelli, Eleftheria Kalaitzaki, David Watkins, Naureen Starling, Ian Chau, Sheela Rao

The Oncologist 2017; 22:402-408; first published on February 16, 2017; doi:10.1634/theoncologist.2016-0241


European Articles Archive

Links to other domains will open in a new tab or window.